Contact: Linda Muskat-Rim , 914-740-2100, firstname.lastname@example.org
Genetic Engineering & Biotechnology News (GEN) Celebrates 30 Years with 130-Page Collector's Edition
New Rochelle, NY, October 3, 2011-Genetic Engineering & Biotechnology News (GEN) celebrates 30 years as the world's first and most widely read magazine for the biotechnology industry. Universally heralded as the definitive information source in this field, GEN covers the technology, trends, products, services, and advances that shape and drive the industry forward. GEN's 130-page commemorative issue features articles written by luminaries, and an original poster that tracks the milestones that have altered the course of biotechnology, leading to today's most groundbreaking scientific and therapeutic discoveries.
"Genetic Engineering & Biotechnology News was there at the inception of this field and remains the single most useful resource I use for keeping abreast of new developments," said James Wilson, M.D., Ph.D., Professor of Pathology and Laboratory Medicine, Gene Therapy Program, University of Pennsylvania School of Medicine.
GEN was founded in 1981 by Mary Ann Liebert, who identified the untapped need for a publication dedicated to the rapidly evolving biotech industry from applied research through commercialization. David Weiner, Ph.D., Professor of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, said, "Mary Ann practically willed the biotech revolution."
"GEN is biotechnology. It always has been and always will be," said Mary Ann Liebert, president and CEO of the company that bears her name. John Sterling, GEN's Editor-in-Chief for the past 27 years, confirms that "Genetic Engineering & Biotechnology News impacts the industry. It fosters critical international collaborations among academia, industry, and government."
Publishing October 1, the Collector's Edition includes contributions from Leroy Hood, M.D., Ph.D., on Biological Complexity Under Attack; James M. Wilson, M.D., Ph.D., on The History and Promise of Gene Therapy; Elaine R. Mardis, Ph.D., on Future of DNA Sequencing Technology; Rita Colwell, Ph.D., on Combating Infectious Disease Agents; N. Leigh Anderson, Ph.D., on Proteomics: Pathways and Biomarkers; G. Steven Burrill on Tracking Operational Financing Trends; and articles on bioprocessing and synthetic biology.
Over the years, GEN's guest editorials have been penned by notables including: Presidents Bill Clinton and Jimmy Carter; Vice Presidents Al Gore and Dan Quayle; Speaker of the House Newt Gingrich; Nobel Prize Winner and co-discoverer of the structure of DNA, James D. Watson, Ph.D.; former Head of 20th Century Fox and Co-Founder of Stand Up To Cancer, Sherry Lansing; and J. Craig Venter, Ph.D., leader of a team that decoded the human genome. GEN enjoyed its own celebrity and a film credit as a scientific consultant for the hit film Jurassic Park.